- recruitingPHASE3
Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy
This study is for people with a type of cancer called GEP-NETs that has grown after previous treatment. It tests a new medicine, RYZ101, against standard treatments to see if it is safe and works better in stopping the cancer's growth.
United States · Belgium · Brazil - recruitingPHASE3
Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen
This study is testing a new medicine, paltusotine, for people with carcinoid syndrome. It aims to see if paltusotine can help reduce symptoms like flushing and diarrhoea safely, compared to a dummy pill.
United States · Argentina · Brazil